Presence of post-concussion syndrome symptoms in patients with chronic pain vs mild traumatic brain injury

Brain Injury ◽  
2003 ◽  
Vol 17 (3) ◽  
pp. 199-206 ◽  
Author(s):  
Laura Smith-Seemiller ◽  
Neil R. Fow ◽  
Ravi Kant ◽  
Michael D. Franzen
2017 ◽  
Vol 58 (4) ◽  
pp. 545-558 ◽  
Author(s):  
Anders C. Meidahl ◽  
Andreas Eisenried ◽  
Michael Klukinov ◽  
Longhui Cao ◽  
Alexander Z. Tzabazis ◽  
...  

2014 ◽  
Vol 24 (2) ◽  
pp. 117-124
Author(s):  
Céline Balzani ◽  
Anne-Sophie Mariaud ◽  
Daniele Schön ◽  
Michel Cermolacce ◽  
Jean Vion-Dury

2021 ◽  
Vol 57 (2) ◽  
pp. 191-198
Author(s):  
Victor M. Pedro ◽  
◽  
Nicole C. Lim ◽  
Elena Oggero ◽  
◽  
...  

Post-Concussion Syndrome (PCS) is a relatively prevalent condition that emerges after sustaining a head injury. Individuals with PCS experience prolonged impairments and distress associated with the injury which can impact the individuals’ quality of life experiences. In this retrospective chart review of refractory adult patients diagnosed with PCS and mild Traumatic Brain Injury (mTBI), the effectiveness of Cortical Integrative Therapy (PedroCIT®) was investigated by comparing measures of postural stability, brain sequencing and timing, and self-reports of physical and psychosocial symptoms of PCS obtained before and after PedroCIT®. Multivariate and Repeated Measures General Linear Models showed improvements across the measures from before to after treatment in all subjects, highlighting the effectiveness of PedroCIT®. To further underscore the capacity of PedroCIT® to elicit improvements in patients who have been resistant to treatment prior to PedroCIT®, the duration of time that the subjects underwent PedroCIT® was compared to the duration of time since the injury to the subjects’ first PedroCIT® intervention session. The findings of this study showed significant improvements from pre- to post-treatment in postural stability, brain sequencing and timing, and self-reported symptoms for patients affected by PCS and mTBI, and treatment outcomes were largely not contingent upon the severity of the condition at the beginning of treatment. Altogether, this retrospective study suggests that refractory individuals affected by PCS and mTBI can benefit from undergoing PedroCIT® and their treatment outcomes may not be related to the degree of impairment presented at the beginning of treatment.


Sign in / Sign up

Export Citation Format

Share Document